Melhores CyberKnife para cancro do pulmão CyberKnife para cancro do pulmão em Israel - TOP-4 médicos

Chefe da Unidade de Oncologia de Tecidos Moles e Ósseos no Centro Médico Sourasky – é especializado em tratamentos avançados para câncer de pulmão, incluindo o CyberKnife.

• Mais de 25 anos de experiência em oncologia
• Fellowship (Bolsa de Especialização) em sarcoma no Institut Gustave Roussy, Paris
• Membro do corpo docente do grupo Sarcoma da ESMO
• Pesquisa publicada sobre imunologia tumoral e malignidades ósseas

O Dr. Ari Raphael lidera pesquisas pioneiras em câncer de pulmão com mais de 5 ensaios clínicos como investigador principal, incluindo técnicas avançadas de perfil genômico no Sourasky Medical Center.

• Especialista em malignidades torácicas e perfil genômico abrangente
• Investigador principal em ensaios de ponta sobre imunoterapia e aplicações de biópsia líquida
• Moderador do Molecular Tumor Board para a Sociedade Israelense de Câncer de Pulmão
• Treinado no Guy's Hospital London em ensaios de fase inicial de câncer de pulmão
• Homenageado com bolsas de pesquisa e prêmios de ensino em oncologia

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.